Clinical studyFungus infections associated with antibiotic and steroid therapy
References (43)
The growth of Candida albicans during antibiotic therapy
Lancet
(1954)Moniliasis pneumonia following aureomycin therapy
Lancet
(1952)- et al.
The effect of aureomycin and chloromphenicol on the fungal and bacterial flora of children
New England J. Med.
(1953) - et al.
A study of moniliasis in aureomycin therapy
- et al.
Fatal fungus infections, complicating antibiotic therapy
J.A.M.A.
(1953) - et al.
Fatal generalized moniliasis
Am. J. Clin. Path.
(1951) Mycosis of cervical spinal cord following intrathecal penicillin therapy
Arch. Path.
(1952)- et al.
Mycotic endocarditis due to Candida albicans
J.A.M.A.
(1952) Are fungus infections increasing as a result of antibiotic therapy
J.A.M.A.
(1952)Clinical studies with ACTH in bronchial asthma
Systemic moniliasis and aspergillosis complicating corticotropin therapy
Arch. Int. Med.
(1955)
The influence of ACTH and cortisone on the incidence of infections
J. Lab. Clin. Med.
(1954)
Candida and asperigillus endocarditis
Arch. Path.
(1950)
Pulmonary mucormycosis
Am. J. Path.
(1956)
Mucormycosis of the central nervous system
Bull. Johns Hopkins Hosp.
(1943)
Pathogenesis of Candida albicans infection following antibiotic therapy. II. Further studies of the effect of antibiotics on the in vitro growth of Candida albicans
J. Bact.
(1955)
Pathogenesis of Candida albicans infection following antibiotic therapy. I. The effect of antibiotics on the growth of Candida albicans
J. Bact.
(1953)
Virulence enhancement of Candida albicans by antibiotics and cortisone
Virulence enhancing activities of aureomycin on Candida albicans
Protective action of fungicidin (nystatin) in mice against virulence enhancing activity of oxytetracycline on Candida albicans
Antibiotics & Chemother.
(1953)
Inhibition of phagocytosis by aureomycin
Cited by (86)
Specialization and medical mycology in the US, Britain and Japan
2008, Studies in History and Philosophy of Science Part C :Studies in History and Philosophy of Biological and Biomedical SciencesNeutropenia and neoplasia: An overview of the pharmacoeconomics of sargramostim in cancer therapy
1997, Clinical TherapeuticsPulmonary mucormycosis
1996, Seminars in RoentgenologyPrevalence and Associated Factors of Toenail Onychomycosis Among Patients with Diabetes in Jordan
2024, Current Diabetes ReviewsPrognostic factors of cirrhotic patients with invasive fungal infections
2023, Medicine (United States)Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital
2023, Indian Journal of Dental Research
- 1
From the Laboratory Division, Montefiore Hospital, New York, N. Y.
Copyright © 1957 Published by Excerpta Medica Inc.